Photo: The Economic Times
Union Govt Claims Covishield, Covaxin Effective Against SARS-CoV-2
The Union Government has addressed that 'Covishield' produced by Serum Institute, and 'Covaxin' by Bharat Biotech is assumed to be effective against SARS-CoV-2 variants Delta, Alpha and Gamma. However, the efficacy test is still under process and results will be out within the next week. As per the ICMR Director General, Balram Bhargava, Covishield reduces its efficiency by 2.5 times with Alpha while Covaxin is potent with Delta.
Tags: Covid-19, SARs-CoV-2 virus, COVISHIELD, Covaxin, Covid-19 Vaccine
Courtesy: Times Now Digital
Photo: The Economic Times
Govt To Speed Up Vaccine Production, 13.5 Crore Doses To Be Available In July
Production of vaccination has been ramped up to make 13.5 crore doses available by July. Top sources in the government have said that 75% of these doses will go to state governments for free vaccinations. These vaccine doses will be administered to patrons above the age of 18. States will consolidate demand for private hospitals under the new rules, with an eye towards equal distribution among big and small private hospitals.
Tags: Covid-19, Vaccination, Covaxin, COVISHIELD
Courtesy: The Indian Express
Photo: Los Angeles Times
People Traveling Abroad for Studies Eligible For Second Dose of Vaccine: Delhi
The Delhi government has made people travelling abroad for studies, work and sporting events, eligible for the second dose of Covishield vaccine from a dedicated facility. A centre has been established at Navyug School in Mandir Marg for those who wish to travel abroad before August 31. The eligible candidates must furnish documents proving the reason for the foreign trip, as… read-more
Tags: Covid-19, International Travel, studies, COVISHIELD
Courtesy: The Quint
Photo: Live Law
20 Villagers In UP's Siddharthnagar Get Mixed Covishield+Covaxin Shots
In an incident of medical negligence blamed on 'oversight', a group of 20 villagers in UP’s Siddharthnagar were given a mixed dose of Covishield+Covaxin at government hospital. Jabbed with Covishield as their first dose in April first week, they were administered with Covaxin as second dose on May 14. While the worried villagers have reported no adverse effects yet, Siddharthnagar CMO has assured of strict action against responsible people.… read-more
Tags: Covaxin, COVISHIELD, CMO, Oversight, Uttar Pradesh, Siddharthnagar
Courtesy: NDTV
Photo: Business Standard
Bharat Biotech's Covaxin Trials On Kids Likely To Begin In June
Bharat Biotech on May 23 stated it would begin trials of its COVID-19 vaccine Covaxin on children from June. "Kids vaccine trials of Bharat Biotech may get the license in third quarter of this year," stated an official of the company. Besides, the vaccine-maker is also eyeing to increase Covaxin manufacturing capacity to 700Mn doses by 2021 end as "the government placed an advanced purchase order of Rs 1,500 crore".
Tags: Bharat biotech, Covaxin, Covid -19, COVISHIELD
Courtesy: The Times of India
Photo: ABC News
India's Decision To Extend Covishield Dose Gap Reasonable: Dr Fauci
White House's chief medical advisor Dr Anthony Fauci has backed India's decision to extend Covishield dose-gap from 6-8 weeks to 12-16 weeks. Refuting "cover-up" claims for shortage, Fauci called the decision "reasonable" saying, "it is unlikely that long delay would have a negative effect on vaccine efficacy." Earlier, he had also advised India for extensive vaccination and a complete lockdown to contain the second wave of COVID-19.
Tags: Dr Anthony Fauci, India, COVISHIELD, Dose Gap
Courtesy: India Today
Photo: Scroll
Govt Panel Wants Covishield Dose Gap To Be Increased To 12-16 Weeks
As India runs short of vaccines, the National Technical Advisory Group on Immunization has recommended extending the Covishield dose-gap to 12-16 weeks. It also advised lab-tested COVID-19 patients to defer from vaccination for six months after recovering. Besides, it said the pregnant women will be allowed to choose between the two vaccines and lactating ones can get vaccinated anytime after delivery. Meanwhile, there are no updates for… read-more
Tags: NTAGI, COVISHIELD, Covaxin, Covid-19, Dose Gap
Courtesy: The Times of India
Photo: Indian Express
Pvt Centers To Let Individuals Select Their Preferred Vaccine From May 1
People, who register to get the COVID-19 vaccine from May 1 in private inoculation centres, can choose their preferred vaccine on the CoWIN platform as well. Moreover, the Health Ministry has instructed private inoculation centres to mention necessary details, including availability of stocks and the price, on the platform. Earlier, registered individuals could only choose the location of the vaccine centre. India currently offers two… read-more
Tags: Covid-19, Covaxin, COVISHIELD, Private Hospitals, Corona Crisis
Courtesy: News18
Photo: The Economic Times
SII To Sell Covishield At Rs 600 To Pvt Hospitals, Rs 400 To States
The Serum Institute of India on April 21 announced to sell its Covishield vaccine to state governments at Rs 400 and to the private hospitals at Rs 600/dose. SII said that 50% of its forthcoming vaccine production will be dedicated to Centre’s vaccination program and other 50% for states and private hospitals. Welcoming the Centre’s liberalised vaccination policy, SII assured that vaccines will be available in 4-5 months.
Tags: SII, COVISHIELD, Central Government, Covid-19 Vaccine, Private Hospitals
Courtesy: Live Mint
Photo: Business Standard
AstraZeneca Sends Legal Notice To SII Over Delays In Vaccine Supply
British-Swedish pharmaceutical company AstraZeneca has served a legal notice to the Serum Institute of India over delays in the supply of COVID-19 vaccine Covishield. SII CEO Adar Poonawalla said, “Serum Institute is not able to fulfil (contractual obligations) due to its prioritisation of Indian supplies." Moreover, denying to comment on the notice and terming it "confidential", Poonawalla said the company is trying to resolve and manage the… read-more
Tags: COVISHIELD, Adar Poonawalla, SII, AstraZeneca
Courtesy: NDTV
